Our News on Newswise

Study suggests that unintentional weight loss is a signal to see a doctor

Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming year, according to a study from Dana-Farber Cancer Institute.
23-Jan-2024 10:05 AM EST Add to Favorites

Newswise: 659c30c9e785e_DanaFarberExterior.jpg

Blood test distinguishes neuroendocrine subtype of advanced prostate cancer

Researchers at Dana-Farber Cancer Institute and the University of Trento, Italy, have developed a blood test, described in Cancer Discovery, that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant...
9-Jan-2024 2:05 PM EST Add to Favorites

Novel Compound Protects Against Infection by Virus that Causes COVID-19, Preliminary Studies Show

• Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of COVID-19 in tests with hamsters
5-Jan-2024 2:05 PM EST Add to Favorites

Newswise: 6568c20911f7f_GeorgeDemetriMD.jpg

George Demetri, MD, of Dana-Farber earns Lifetime Achievement Award in Medicine from Stanford University School of Medicine

George Demetri, MD, director of the Sarcoma Center at Dana-Farber Cancer Institute, is being awarded the prestigious J.E. Wallace Sterling Lifetime Achievement Award in Medicine from the Stanford Medicine Alumni Association (SMAA).
30-Nov-2023 12:05 PM EST Add to Favorites

Treatment strategy for certain advanced prostate cancers shows promise in preclinical models

Patients with advanced prostate cancer with tumors harboring RB1 gene loss or neuroendocrine features often have a poor prognosis and limited treatment options.
14-Nov-2023 2:05 PM EST Add to Favorites

Newswise: 65525d9d30f3f_PaulMarksWinners.jpg

Cigall Kadoch, PhD, of Dana-Farber awarded 2023 Paul Marks Prize for cancer research

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.
13-Nov-2023 12:05 PM EST Add to Favorites

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

Cabozantinib, which targets tumor cell growth and tumor blood vessel growth, sharply improved progression-free survival over placebo in patients with extra-pancreatic and pancreatic neuroendocrine tumors
22-Oct-2023 2:30 AM EDT Add to Favorites

Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimus

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with...
20-Oct-2023 10:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Movie release prompts national conversation about colorectal cancer in the Black community

Marvel Studios’ movie, “Black Panther: Wakanda Forever,” is the highly anticipated sequel to “Black Panther,” hitting theaters on November 11th. It will premiere without “Black Panther” star Chadwick Boseman, who passed away in 2020...
8-Nov-2022 3:05 PM EST

Newswise: Yawkey Building 2.jpg

Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

See All Experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Experts

Contacts

Ellen Berlin
Senior Director, External Communications

ellen_berlin@dfci.harvard.edu

617-632-5357

Victoria Warren
Media Relations Manager
GI/GU

Victoria_Warren@dfci.harvard.edu

617-582-9323

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Rob Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Media

media@dfci.harvard.edu

Cindy Cantrell
Senior Media Relations Specialist

cindy_cantrell@dfci.harvard.edu

Erica Hinsley
Associate Director, External Communications

erica_hinsley@dfci.harvard.edu

508-479-3650

Nicole Oliverio
Senior Media Relations Specialist

Nicole_Oliverio@dfci.harvard.edu

617-257-0454

Twitter

Instagram

Instagram feed not yet configured. Click "Edit Instagram Feed" to enter your Instagram details.
close
0.31185